Open
Actively Recruiting
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
About
Brief Summary
Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.
Study Type
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Adult patients admitted to the Surgical, Cardiothoracic or Neuro ICU
- ICU stay longer than 24 hours
Exclusion Criteria:
- Patients with muscular or mitochondrial diseases affecting muscle quality or mass
- Preexisting paralysis
- Absence of lower limbs
- Ongoing discussions about goals of care
- Transfers from a skilled nursing facility
- Children under the age of 18
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
20-002271
Category
Anesthesiology & Perioperative Medicine
Principal Investigator
Contact
Location
- UCLA Westwood